Episode 68: Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy

episode

AACE Podcasts not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Group Dating Shift_ Why Connection is a Team Sport (Part 2) (1) 2 min · 26 Sep 2026 · Conspiracy Theories Exploring The Unseen

The End of the Endless Swipe_ Why Group Dating is the New Norm (Part 1) 2 min · 26 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Invisible Divide_ Part 4 2 min · 26 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Invisible Line_ Is Resegregation the New Norm_ (Part 3) ( 2 min · 26 Sep 2026 · Conspiracy Theories Exploring The Unseen

‘An absolute balls of this!’ - IRE v ISR fiasco | The Green Scene | OFF THE BALL 33 min · 26 Sep 2026 · OTB Football

The Invisible Wall_ Part 2 2 min · 26 Sep 2026 · Conspiracy Theories Exploring The Unseen

Report any issue

Source

Recorded29 Sep 2025

Publisherfeeds.buzzsprout.com

Handlerec:14280166

Show notes

Join Elizabeth M. Bauer, MD, FACP, FACE, Dipl ABOM, as she interviews Nicholas A. Tritos, MD, DSc, Professor of Clinical Medicine at Harvard Medical School and faculty of the Neuroendocrine Unit/Neuroendocrine and Pituitary Tumor Clinical Center at Massachusetts General Hospital, about his Endocrine Practice article, Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy – How Concerned Should We Be? The conversation explores the prevalence and risk factors for impulse control disorders, underlying biological mechanisms, clinical screening strategies, and approaches to patient counseling and management. Read the full article in the July 2025 issue of Endocrine Practice here: https://doi.org/10.1016/j.eprac.2025.04.018

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in